Sanara Medtech INC Form 4 insider transactions

NASDAQ
Michael McNeil, CFO of Sanara MedTech Inc., reports the acquisition of 4,650 shares of restricted stock granted under the company's 2014 Omnibus Long Term Incentive Plan.
NASDAQ
Sanara MedTech's CEO, Zachary Fleming, reports the withholding of shares to cover tax obligations related to vesting restricted stock.
NASDAQ
Michael McNeil, CFO of Sanara MedTech Inc., reports the withholding of common stock by the company to cover tax obligations related to the vesting of restricted stock.